Editing the Human Genome
By BBC Newshour Extra,
BBC Newshour Extra
| 11. 28. 2015
Remarkable new techniques for ‘editing’ DNA – chemically cutting and splicing sections of genetic code – are revolutionising research in laboratories around the world. The potential for eradicating hereditary diseases is enormous. But are the benefits outweighed by the risks involved? And should these techniques ever be used on humans? On Newshour Extra this week, Owen Bennett Jones and his panel of expert guests discuss the scientific and ethical consequences of this latest research, and ask whether mankind should be tinkering with our genetic inheritance.
Contributors: Prof Robin Lovell-Badge - Head of Stem Cell Biology and Developmental Genetics at the Francis Crick Institute; Michael Le Page -New Scientist magazine; Dr Annelien Bredenoord - Associate Professor of Biomedical Ethics at the University Medical Centre in Utrecht; Marcy Darnovsky - Executive Director of the Center for Genetics and Society, Berkeley, California; James Rushbrooke - playwrite; Edward Perello - co-founder of Desktop Genetics
Related Articles
What We Inherit by Sam Trejo and Daphne O. Martschenko; and Original Sin by Kathryn Paige Harden have a great deal in common, with substantial differences in style and emphasis. Both books attempt, in different ways, to show the reader just where current research into human genomics stands, where that might be going, and why the authors are interested. In short, the influence of genomic research on our societies is already large and seems likely to change them in ways...
By Dan Falk, Nautilus | 08.20.2026
The pseudoscience of eugenics, founded on the mistaken notion that nature envisions some “right” combination of genes, and that selective breeding can improve the human race, is making a comeback. While the heyday of eugenics was a century ago, the...
By Emily Packard Dawson and Lainie Friedman Ross, MedPage Today | 08.18.2026
Few things evoke a greater sense of desperation than a parent seeking an experimental treatment for their child. That desperation can make even extraordinary risks seem worth taking. This dynamic has come into stark relief after Mei, a 6-year-old girl...
By Ryan Cross, Endpoints News | 08.20.2026
China’s cheap, fast and quiet system for testing cutting-edge medicines is facing scrutiny after the deaths of three people in investigator-initiated trials.
The studies, also known as IITs, allow experimental cell and gene therapies to be tested without oversight from...